Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
20.8M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
2.61M
-
Shares change
-
+362K
-
Total reported value, excl. options
-
$4.33M
-
Value change
-
+$649K
-
Number of buys
-
6
-
Number of sells
-
-7
-
Price
-
$1.66
Significant Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI) as of Q3 2025
26 filings reported holding CASI - CASI Pharmaceuticals, Inc. - Ordinary Shares as of Q3 2025.
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.61M shares
of 20.8M outstanding shares and own 12.56% of the company stock.
Largest 10 shareholders include VR ADVISER, LLC (987K shares), Foresite Capital Management VI LLC (980K shares), BANK OF AMERICA CORP /DE/ (255K shares), Woodline Partners LP (166K shares), Wellington Shields Capital Management, LLC (69.5K shares), RENAISSANCE TECHNOLOGIES LLC (43.9K shares), TWO SIGMA INVESTMENTS, LP (33.3K shares), Wellington Shields & Co., LLC (30.1K shares), GEODE CAPITAL MANAGEMENT, LLC (18.8K shares), and Ground Swell Capital, LLC (10.1K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.